Related Experiment Video
Updated: May 2, 2026

10:05
Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells
Published on: September 30, 2018
10.1K
Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells
Bijan Akbari1, Abdulshakour Mohammadnia2, Moein Yaqubi3
1Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Journal of Cellular Biochemistry
|April 13, 2017
Summary
This study identified 16 key transcription factors (TFs) that regulate gene expression in pancreatic cancer. Upregulated FOXM1 is a major driver of pancreatic cancer development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Pancreatic cancer exhibits high mortality due to rapid progression and limited effective treatments.
- The molecular mechanisms driving altered gene expression in pancreatic cancer are not fully understood.
Purpose of the Study:
- To comprehensively analyze gene expression data from pancreatic cancer.
- To identify key transcription factors (TFs) and biological pathways affected in pancreatic cancer.
- To elucidate the regulatory mechanisms underlying gene expression alterations.
Main Methods:
- Meta-analysis of gene expression data from 282 pancreatic tumor and normal samples across seven datasets.
- Identification of common differentially expressed genes (DEGs) and affected biological processes.
- Analysis of transcription factor (TF) regulatory networks and their role in pancreatic cancer.
Main Results:
- Identified 16 differentially expressed transcription factors (DE-TFs) significantly regulating gene expression in pancreatic cancer.
- Highlighted common DEGs and affected biological pathways across independent datasets.
- FOXM1 was identified as a top regulator of pancreatic cellular transformation, influencing gene regulatory networks and cancer-specific pathways.
Conclusions:
- Bioinformatics meta-analysis clarified common gene expression profiles and regulatory mechanisms in pancreatic cancer.
- Identified DE-TFs, particularly FOXM1, offer potential targets for pancreatic cancer screening and novel pharmacological interventions.

